Cargando…
Targeted inhibition of the COP9 signalosome for treatment of cancer
The COP9 signalosome (CSN) is a central component of the activation and remodelling cycle of cullin-RING E3 ubiquitin ligases (CRLs), the largest enzyme family of the ubiquitin–proteasome system in humans. CRLs are implicated in the regulation of numerous cellular processes, including cell cycle pro...
Autores principales: | Schlierf, Anita, Altmann, Eva, Quancard, Jean, Jefferson, Anne B., Assenberg, René, Renatus, Martin, Jones, Matthew, Hassiepen, Ulrich, Schaefer, Michael, Kiffe, Michael, Weiss, Andreas, Wiesmann, Christian, Sedrani, Richard, Eder, Jörg, Martoglio, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078989/ https://www.ncbi.nlm.nih.gov/pubmed/27774986 http://dx.doi.org/10.1038/ncomms13166 |
Ejemplares similares
-
The COP9 Signalosome: A Multi-DUB Complex
por: Dubiel, Wolfgang, et al.
Publicado: (2020) -
Conservation of the COP9/signalosome in budding yeast
por: Wee, Susan, et al.
Publicado: (2002) -
Targeting the COP9 signalosome for cancer therapy
por: Du, Wenqi, et al.
Publicado: (2022) -
The Evolution of COP9 Signalosome in Unicellular and Multicellular Organisms
por: Barth, Emanuel, et al.
Publicado: (2016) -
Tackling the crystallographic structure determination of the COP9 signalosome
por: Bunker, Richard D.
Publicado: (2016)